New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
11:11 EDTCREE, YRCW, ARIA, ICPT, EXELOptions with decreasing implied volatility: ICPT YRCW EXEL ARIA CREE
News For ICPT;YRCW;EXEL;ARIA;CREE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 28, 2015
10:40 EDTCREEOptions with decreasing implied volatility
Options with decreasing implied volatility: INFN VDSI AMZN PII CREE CMG P SYNA SONS FFIV
April 27, 2015
11:19 EDTCREEOptions with decreasing implied volatility
Subscribe for More Information
April 24, 2015
10:22 EDTCREEOptions with decreasing implied volatility
Subscribe for More Information
April 23, 2015
10:30 EDTCREEOptions with decreasing implied volatility
Options with decreasing implied volatility: NLNK PNK INFN WUBA MLNX CREE SKX CMG NOW FTNT
05:44 EDTICPTIntercept FLINT trial data shows OCA treatment increases fibrosis resolution
Subscribe for More Information
April 22, 2015
12:31 EDTCREEOn The Fly: Top stock stories at midday
Stocks on Wall Street were higher at midday after having been on a bit of a see-saw during morning trading. The averages opened in positive territory, soon turned negative, then back into positive ground following the release of a better than expected existing home sales report. The housing data was followed by a lift in the averages, which remained in positive ground near noon. ECONOMIC EVENTS: In the U.S., existing home sales rose 6.1% to a 5.19M rate in March, which was better than the expected 3.1% increase to a rate of 5.03M. Crude oil inventories built up by 5.32M barrels last week, which was more than the consensus forecast for a 3.2M barrel build. In Asia, Japan's Nikkei 225 average closed above 20,000 for the first time since April 2000. In Europe, Germany raised its economic growth forecast for 2015 to 1.8%, which was up from the 1.5% growth it said it expected in January. COMPANY NEWS: Shares of McDonald's (MCD) advanced 2% after the company reported headline earnings that missed expectations but also said it is developing a turnaround plan to improve its performance and deliver "enduring profitable growth" that it plans to share in the first week of May. Also rising after its quarterly report was another globally recognized brand, Coca-Cola (KO), whose shares gained 1% after its comparable earnings per share topped the consensus estimate. A third member of the Dow, Boeing (BA), slid over 2.5% after its earnings beat expectations but its revenue fell short of the consensus forecast... Visa (V) rose 5% and MasterCard (MA) advanced over 4% after China's State Council announced overnight that the country will regulate the market access for bankcard transaction clearing institutions, which analysts think might allow both companies to compete for the processing of domestic transactions in the country. MAJOR MOVERS: Among the notable gainers was Angie's List (ANGI), which jumped 12% after the company reported it was profitable in the first quarter and announced an exclusive relationship that will see carpet manufacturer Shaw Industries give the company's members exclusive product offers. Also higher was ASML (ASML), which gained 11% after announcing that it has signed an agreement with one of its "major U.S. customers" to deliver a minimum of 15 ASML EUV, or Extreme Ultraviolet, lithography systems. Afterward, Summit Research said it thinks the most likely buyer is Intel (INTC), which the firm believes does not want to be left behind if TSMC (TSM) puts EUV to use in 10nm processing. Among the noteworthy losers was Natural Resource Partners (NRP), which dropped 19% after the company slashed its quarterly distribution by 75% to 9c per unit. Also lower following their earnings reports were ADTRAN (ADTN), which fell over 9%, Cree (CREE), which slid 9%, and Chipotle Mexican Grill (CMG), which declined 6%. INDEXES: Near midday, the Dow was up 28.69, or 0.16%, to 17,978.28, the Nasdaq was up 6.66, or 0.13%, to 5,020.77, and the S&P 500 was up 5.24, or 0.25%, to 2,102.53.
11:25 EDTCREEStocks with call strike movement; TWTR CREE
Twitter (TWTR) September 60 call option implied volatility increased 3% to 42, Cree (CREE) August 37.5 call option implied volatility decreased 11% to 34 according to IVolatility.
10:53 EDTCREEOptions with decreasing implied volatility
Subscribe for More Information
09:22 EDTCREEOn The Fly: Pre-market Movers
UP AFTER EARNINGS: CalAmp (CAMP), up 12.7%... Angie's List (ANGI), up 17.4%... Broadcom (BRCM), up 6.3%... Owens Corning (OC), up 3.8%... Yum! Brands (YUM), up 3.3%... Dolby Laboratories (DLB), up 3.6%... Infinera (INFN), up 2.4%... AutoNation (AN), up 2.5%... Amgen (AMGN), up 3.1%... Coca-Cola (KO), up 2%. ALSO HIGHER: Procera Networks (PKT) up 10.4% after being acquired by Francisco Partners in deal valued at $240M... Organovo (ONVO), up 19.2% after entering into a collaboration agreement with Merck Sharp and Dohme... Vical (VICL), up 5.8% after being awarded $4M contract to manufacture HIV vaccines for clinical evaluation... CTI BioPharma (CTIC), up 4.9% after announcing that Phase 3 pacritinib data will be highlighted in a late-breaking oral presentation at ASCO meeting. DOWN AFTER EARNINGS: Chipotle Mexican Grill (CMG), down 5.2%... iRobot (IRBT), down 3.6%... Cree (CREE), down 3.5%... United Rentals (URI), down 4%... Super Micro Computer (SMC), down 2.3%... Thermo Fisher (TMO), down 2.6%. ALSO LOWER: Natural Resource Partners (NRP), down 14% after reducing quarterly distribution 75% to 9c per unit... Trinity Industries (TRN), down 3.5% following a Bloomberg report that the Justice Department has initiated a criminal investigation into Trinity guardrails.
07:38 EDTARIAARIAD issued U.S. patent on brigatinib
Subscribe for More Information
07:07 EDTICPTEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
April 21, 2015
19:06 EDTCREEOn The Fly: After Hours Movers
Subscribe for More Information
16:12 EDTCREECree slides after results
In the extended session shares are currently down more than 5% to $33.54. At that price next support is at $32.73. Resistance is at $34.58.
16:05 EDTCREECree sees Q4 EPS 24c-28c, consensus 29c
Subscribe for More Information
16:02 EDTCREECree reports Q3 adjusted EPS 22c, consensus 23c
Subscribe for More Information
15:28 EDTCREENotable companies reporting after market close
Subscribe for More Information
14:30 EDTARIAARIAD could be worth double current value to strategic buyer, BBJ BioFlash says
Subscribe for More Information
13:58 EDTCREEEarnings Watch: Cree to report Q3 results as LED sector gains momentum
Subscribe for More Information
07:36 EDTARIAARIAD anounces results of preclinical studies on Brigatinib at AACR meeting
ARIAD Pharmaceuticals announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor, brigatinib at the American Association for Cancer Research Annual Meeting 2015. Brigatinib is in development for the treatment of patients with anaplastic lymphoma kinase positive metastatic non-small cell lung cancer, who are resistant to crizotinib. An oral presentation describes, for the first time, the design and chemical structure of brigatinib, discovered using ARIADís structure-based drug design platform. With the goal of designing a selective ALK inhibitor with broad-based activity against crizotinib-resistant mutants, ARIAD scientists advanced a series of novel compounds culminating in the identification of brigatinib. Brigatinib incorporates unique chemical-design features, including the distinctive use of a recognition element that confers favorable pharmacologic properties. Brigatinib has at least 10-fold greater potency than crizotinib against ALK+ NSCLC cell lines and was broadly active against clinically relevant crizotinib-resistant mutants in preclinical models. A poster presentation shows that brigatinib, at clinically achievable concentrations, has potent anti-tumor activity against a panel of 17 distinct ALK mutants known to confer resistance to other ALK inhibitors. In a separate study designed to model the occurrence of brain metastases in ALK+ lung cancer patients, brigatinib significantly reduced the tumor burden in mice with ALK+ brain tumors compared to the tumors in mice treated with crizotinib. Survival of brigatinib-treated mice was also markedly enhanced compared to the survival duration of crizotinib-treated mice.
April 20, 2015
07:20 EDTEXEL, ARIAAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use